WordNet

an additive that enhances the effectiveness of medical treatment
enhancing the action of a medical treatment; "the adjuvant action of certain bacteria"

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2012/11/30 13:51:23」(JST)

wiki en

An adjuvant (from Latin, adiuvare: to aid) is a pharmacological or immunological agent that modifies the effect of other agents, such as a drug or vaccine. They are often included in vaccines to enhance the recipient's immune response to a supplied antigen, while keeping the injected foreign material to a minimum.^[1]^[2]

Immunologic adjuvants

Main article: Immunologic adjuvant

Immunologic adjuvants are added to vaccines to stimulate the immune system's response to the target antigen, but do not in themselves confer immunity. Adjuvants can act in various ways in presenting an antigen to the immune system. Adjuvants can act as a depot for the antigen, presenting the antigen over a long period of time, thus maximizing the immune response before the body clears the antigen. Examples of depot type adjuvants are oil emulsions. Adjuvants can also act as an irritant which causes the body to recruit and amplify its immune response.^[3] A tetanus, diphtheria, and pertussis vaccine, for example, contains minute quantities of toxins produced by each of the target bacteria, but also contains some aluminium hydroxide.^[4] Such aluminium salts are common adjuvants in vaccines sold in the United States and have been used in vaccines for over 70 years.^[5] The body's immune system develops an antitoxin to the bacteria's toxins, not to the aluminium, but would not respond enough without the help of the aluminium adjuvant.

Adjuvants as stabilizing agents

Although immunological adjuvants have traditionally been viewed as substances that aid the immune response to antigen, adjuvants have also evolved as substances that can aid in stabilizing formulations of antigens, especially for vaccines administered for animal health.^[3]

References

^ "ABC News: Swine Flu Vaccine: What The Heck Is an Adjuvant, Anyway? (2009)". Abcnews.go.com. 2009-08-11. http://abcnews.go.com/Health/SwineFluNews/story?id=8296948. Retrieved 2010-06-14.
^ "Definition of immunological adjuvant -- NCI Dictionary of Cancer Terms". www.cancer.gov. http://www.cancer.gov/dictionary/?CdrID=43987. Retrieved 2010-08-27.
^ ^a ^b "Adjuvants as stabilizing agents". Benchmark Biolabs, Inc.. http://benchmarkbiolabs.com/resources/about-adjuvants/. Retrieved 3 March 2011.
^ , GlaxoSmithKline, 2009
^ Clapp, Tanya; Siebert, Paul; Chen, Dexiang; Jones Braun, Latoya (2011). "Vaccines with aluminium-containing adjuvants: Optimizing vaccine efficacy and thermal stability". Journal of Pharmaceutical Sciences 100 (2): 388–401. doi:10.1002/jps.22284. PMID 20740674.

External links

http://www.mayoclinic.com/health/adjuvant-therapy/CA00012

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 腹部大動脈瘤ステントグラフト留置術に対する麻酔 anesthesia for endovascular aortic repair
2. 癌免疫療法の原則 principles of cancer immunotherapy
3. 透析患者における赤血球造血刺激因子製剤に対する非鉄薬理学的補助 non iron pharmacologic adjuvants to erythropoiesis stimulating agent therapy in dialysis patients
4. 食物アレルギーに対する今後の治療法 future therapies for food allergy
5. 陣痛および分娩に対する硬膜外・脊椎麻酔：薬 neuraxial analgesia and anesthesia for labor and delivery drugs

English Journal

Oral antigen exposure in newborn piglets circumvents induction of oral tolerance in response to intraperitoneal vaccination in later life.

Pasternak JA1, Ng SH, Buchanan RM, Mertins S, Mutwiri GK, Gerdts V, Wilson HL.
BMC veterinary research.BMC Vet Res.2015 Dec;11(1):350. doi: 10.1186/s12917-015-0350-8. Epub 2015 Mar 7.
BACKGROUND: We previously determined that newborn piglets orally gavaged with Ovalbumin (OVA) responded to systemic OVA re-exposure with tolerance; if adjuvants were included in oral vaccine, piglets responded with antibody-mediated immunity (Vet Immunol Immunopathol 161(3-4):211-21, 2014). Here, we
PMID 25779797

Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection.

Dimier-Poisson I1, Carpentier R2, N'Guyen TT3, Dahmani F2, Ducournau C3, Betbeder D2.
Biomaterials.Biomaterials.2015 May;50:164-75. doi: 10.1016/j.biomaterials.2015.01.056. Epub 2015 Feb 19.
Development of sub-unit mucosal vaccines requires the use of specific delivery systems or immune-modulators such as adjuvants to improve antigen immunogenicity. Nasal route for vaccine delivery by nanoparticles has attracted much interest but mechanisms triggering effective mucosal and systemic immu
PMID 25736506

Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment.

Tsen SW1, Donthi N2, La V2, Hsieh WH2, Li YD3, Knoff J2, Chen A2, Wu TC4, Hung CF5, Achilefu S6, Tsen KT7.
Journal of biomedical optics.J Biomed Opt.2015 May;20(5):051008. doi: 10.1117/1.JBO.20.5.051008.
There is an urgent need for rapid methods to develop vaccines in response to emerging viral pathogens. Whole inactivated virus (WIV) vaccines represent an ideal strategy for this purpose; however, a universal method for producing safe and immunogenic inactivated vaccines is lacking. Conventional pat
PMID 25423046

Japanese Journal

気管支喘息発症にまつわる環境ストレスと心身医学的側面(<特集>呼吸器領域における心身症研究と診療の動向)

丸岡秀一郎,村上正人
心身医学 53(2), 130-135, 2013-02-01
アレルギー疾患の代表的疾患である気管支喘息は,さまざまな環境因子の影響を受けている.ハウスダストダニ抗原やゴキブリ抗原などに代表されるアレルゲンだけではなく,抗原性をもたない環境因子(細菌,オゾン,ディーゼル排気粒子,ウイルス感染,煙草など)も,その免疫賦活作用(アジュバント効果)により病態形成に関与していることが知られている.環境因子を介するエピジェネティクスは心理社会的ストレスも加味されてアレ …
NAID 110009578586

Baicalin From Scutellaria baicalensis Impairs Th1 Polarization Through Inhibition of Dendritic Cell Maturation

Kim Mi Eun,Kim Hyung Keun,Park Hyeon-Young,Kim Dae Hyun,Chung Hae Young,Lee Jun Sik
Journal of Pharmacological Sciences 121(2), 148-156, 2013
… These findings provide important understanding of the immunopharmacological functions of baicalin and have ramifications for the development of therapeutic adjuvants for the treatment of DCs-related acute and chronic diseases. …
NAID 130003362673

Th2アジュバントとしての環境アレルゲンと黄色ブドウ球菌 : 経皮的Th2感作におけるバリア破壊と自然免疫応答

高井敏朗
Journal of environmental dermatology and cutaneous allergology = / the Japanese Society for Dermatoallergology and Contact Dermatitis 6(1), 8-13, 2012-01-31
NAID 10030440954